134 related articles for article (PubMed ID: 2665352)
1. ICRC 'anti-leprosy vaccine'.
Deo MG
Vaccine; 1989 Apr; 7(2):92-3. PubMed ID: 2665352
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic "subunit" of the ICRC antileprosy vaccine.
Chirmule NB; Chaturvedi RM; Deo MG
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):27-35. PubMed ID: 3131465
[TBL] [Abstract][Full Text] [Related]
3. Antigenic profile of ICRC bacilli with special reference to isolation of immunogenic subunit.
Chirmule NB; Mulherkar R; Deo MG
Int Arch Allergy Appl Immunol; 1988; 86(1):19-27. PubMed ID: 3286519
[TBL] [Abstract][Full Text] [Related]
4. Effects of ICRC antileprosy vaccine in healthy subjects.
Chaturvedi RM; Chirmule NB; Yellapurkar MV; Shaikh SU; Deo MG
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):657-66. PubMed ID: 3323368
[TBL] [Abstract][Full Text] [Related]
5. Reversal reaction in lepromatous patients induced by a vaccine containing killed ICRC bacilli--a report of five cases.
Bhatki WS; Chulawala RG; Bapat CV; Deo MG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):466-72. PubMed ID: 6368413
[TBL] [Abstract][Full Text] [Related]
6. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
Jeevan A; Bapat CV
Indian J Lepr; 1984; 56(4):754-63. PubMed ID: 6398339
[TBL] [Abstract][Full Text] [Related]
7. Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
Kale VP; Bapat CV
Indian J Lepr; 1984; 56(2):219-31. PubMed ID: 6387004
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
[TBL] [Abstract][Full Text] [Related]
9. Immunological properties of M. leprae culture isolates ICRC bacilli: hypothesis on relationship between M. leprae and ML-culture isolates.
Bapat CV
Acta Leprol; 1984; 2(2-4):175-94. PubMed ID: 6442820
[TBL] [Abstract][Full Text] [Related]
10. Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers.
Deo MG; Bapat CV; Bhalerao V; Chaturvedi RM; Bhatki WS; Chulawala RG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):540-9. PubMed ID: 6368417
[No Abstract] [Full Text] [Related]
11. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
[TBL] [Abstract][Full Text] [Related]
12. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
13. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
[TBL] [Abstract][Full Text] [Related]
14. A candidate anti-leprosy vaccine from ICRC bacilli.
Deo MG; Chaturvedi RM; Kartikeyan S
Trop Med Parasitol; 1990 Sep; 41(3):367-8. PubMed ID: 2255866
[No Abstract] [Full Text] [Related]
15. Lepromin conversion induced by a 'sub-unit' vaccine from ICRC bacilli.
Bhatki WS; Chullawala RG; Chaturvedi RM; Dixit GM; Deo MG
Indian J Med Res; 1988 Jun; 87():545-54. PubMed ID: 3071521
[No Abstract] [Full Text] [Related]
16. Post-vaccination sensitization with ICRC vaccine.
Vallishayee RS; Gupte MD; Anantharaman DS; Nagaraju B
Indian J Lepr; 1996; 68(2):167-74. PubMed ID: 8835586
[TBL] [Abstract][Full Text] [Related]
17. Potential anti-leprosy vaccine from killed ICRC bacilli--a clinicopathological study.
Deo MG; Bapat CV; Chullawalla RG; Bhatki WS
Indian J Med Res; 1981 Aug; 74():164-77. PubMed ID: 7030942
[No Abstract] [Full Text] [Related]
18. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
19. Comparative leprosy vaccine trial in south India.
Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]